NJ-based Johnson & Johnson says COVID-19 vaccine is safe, showing promising immune response
Johnson & Johnson says its COVID-19 vaccine is safe and showing a promising immune response.
•
Jan 14, 2021, 12:19 PM
•
Updated 1,631 days ago
Share:
More Stories
0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
297ds ago
Hometown Heroes in the Hudson Valley
344ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
489ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
510ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
637ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
637ds ago0:22
Cold Spring Village Hall closed due to COVID-19 surge and staff shortages
297ds agoHometown Heroes in the Hudson Valley
344ds ago1:28
Medical experts recommend to still take precautions following CDC's revised COVID isolation guidelines
489ds ago1:52
Judge: 3 men convicted in COVID-19 relief aid fraud
510ds ago1:47
Wondrous Things store in Briarcliff Manor to close after 34 years; everything 25% off
637ds ago0:28
Rockland small businesses get COVID-19 reimbursement grant
637ds agoJohnson & Johnson says its COVID-19 vaccine is safe and
showing a promising immune response.
The company has reported few
side effects in early trials, things such as headache, muscle aches, and
soreness.
Data shows most volunteers
developed antibodies after 28 days.
Johnson & Johnson's
vaccine requires only one dose, while Pfizer's and Moderna's require two.
More from News 12
1:49
Thousands head to Kensico Dam Plaza for annual Music Fest & Fireworks
1:56
Cornwall man charged with child sex abuse following complaints from underage boys
1:45
Tattered flag stuck on pole replaced just in time for July 4
0:45
Panel: Standard Amusements can't terminate contract with Westchester County to manage Playland Amusement Park
1:45
Rockland dad claims son unlawfully detained by ICE
0:52
